Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease

Fig. 2

Actuarial probability of remaining survival at different stages of cirrhotic patients (compensated liver cirrhosis). There was a similar probability of survival between compensated patients who were prescribed with intravenous ceftriaxone and those without antibiotic prophylaxis (p = 0.830 by log-rank test)

Back to article page